Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid

Pharmacology Biochemistry and Behavior

Volumn 111, Issue , 2013, Pages 84-89

  Rock, E M ^a   Parker, L A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

5 HT1A; Cannabidiolic acid; Conditioned gaping; Dopamine; Metoclopramide; Nausea

Indexed keywords

ANTIEMETIC AGENT; CANNABIDIOL; CANNABIDIOLIC ACID; CANNABINOID DERIVATIVE; CANNABIS; LITHIUM CHLORIDE; METOCLOPRAMIDE; SACCHARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIEMETIC ACTIVITY; ARTICLE; AVERSION; AVOIDANCE BEHAVIOR; CONDITIONED GAPING; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; LOW DRUG DOSE; MALE; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE;

CANNABIS; RATTUS;

5-HT; 5-HT(1A); 5-HT(3); 5-HT1A; 5-HYDROXYTRYPTAMINE; 5-HYDROXYTRYPTAMINE(1A); 5-HYDROXYTRYPTAMINE(3); CANNABIDIOL; CANNABIDIOLIC ACID; CBD; CBDA; CONDITIONED GAPING; D(2); DA; DOPAMINE; DOPAMINE(2); I.P.; I.V.; INTRAPERITONEALLY; INTRAVENOUSLY; LICL; LITHIUM CHLORIDE; MCP; METOCLOPRAMIDE; NAUSEA; OND; ONDANSETRON; S.C.; SAL; SALINE; SUBCUTANEOUSLY; VEH; VEHICLE;

ANIMALS; ANTIEMETICS; CANNABINOIDS; CONDITIONING (PSYCHOLOGY); LITHIUM CHLORIDE; MALE; METOCLOPRAMIDE; NAUSEA; RATS; RATS, SPRAGUE-DAWLEY; TASTE;

EID: 84884369212     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.08.012     Document Type: Article

References (57)

1. L. Arborelius, G.G. Nomikos, U. Hacksell, and T.H. Svensson (R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex Acta Physiol Scand 148 1993 465 466 (Pubitemid 23234557)
2. E. Ballatori, F. Roila, B. Ruggeri, M. Betti, S. Sarti, and G. Soru The impact of chemotherapy-induced nausea and vomiting on health-related quality of life Support Care Cancer 15 2007 179 185 (Pubitemid 46332920)
3. S. Benloucif, and M.P. Galloway Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis Eur J Pharmacol 200 1991 1 8
4. D. Bolognini, E.M. Rock, N.L. Cluny, M.G. Cascio, C.L. Limebeer, and M. Duncan Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation Br J Pharmacol 168 2013 1456 1470
5. L. Cohen, C.A. de Moor, P. Eisenberg, E.E. Ming, and H. Hu Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings Support Care Cancer 15 2007 497 503 (Pubitemid 46570778)
6. B. Costall, A.M. Domeney, R.J. Naylor, and F.D. Tattersall 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis Neuropharmacology 25 1986 959 961 (Pubitemid 16045969)
7. M. de Boer-Dennert, R. de Wit, P.I. Schmitz, J. Djontono, V. v Beurden, and G. Stoter Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists Br J Cancer 76 1997 1055 1061 (Pubitemid 27434663)
8. P.H. De Mulder, C. Seynaeve, J.B. Vermorken, P.A. van Liessum, S. Mols-Jevdevic, and E.L. Allman Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study Ann Intern Med 113 1990 834 840
9. M. Duran, E. Perez, S. Abanades, X. Vidal, C. Saura, and M. Majem Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting Br J Clin Pharmacol 70 2010 656 663
10. J.J. Fiore, and R.J. Gralla Pharmacologic treatment of chemotherapy-induced nausea and vomiting Cancer Invest 2 1984 351 361 (Pubitemid 15191929)
11. J. Foubert, and G. Vaessen Nausea: the neglected symptom? Eur J Oncol Nurs 9 2005 21 32 (Pubitemid 40361583)
12. R.J. Gralla, L.M. Itri, S.E. Pisko, A.E. Squillante, D.P. Kelsen, and D.W. Braun Jr. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting N Engl J Med 305 1981 905 909 (Pubitemid 11014529)
13. R.J. Gralla, D. Osoba, M.G. Kris, P. Kirkbride, P.J. Hesketh, and L.W. Chinnery Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology J Clin Oncol 17 1999 2971 2994 (Pubitemid 29415258)
14. H.J. Grill, and R. Norgren The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats Brain Res 143 1978 263 279 (Pubitemid 8277909)
15. M. Gupta, M. Davis, S. Legrand, D. Walsh, and R. Lagman Nausea and vomiting in advanced cancer - "The Cleveland Clinic Protocol" J Support Oncol 11 2013 8 13
16. R.A. Harrington, C.W. Hamilton, R.N. Brogden, J.A. Linkewich, J.A. Romankiewicz, and R.C. Heel Metoclopramide. An updated review of its pharmacological properties and clinical use Drugs 25 1983 451 494 (Pubitemid 13130833)
17. J.T. Hickok, J.A. Roscoe, G.R. Morrow, D.K. King, J.N. Atkins, and T.R. Fitch Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community Cancer 97 2003 2880 2886 (Pubitemid 36605158)
18. G.A. Higgins, G.J. Kilpatrick, K.T. Bunce, B.J. Jones, and M.B. Tyers 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret Br J Pharmacol 97 1989 247 255 (Pubitemid 19113970)
19. D.L. Hilarius, P.H. Kloeg, E. van der Wall, J.J. van den Heuvel, C.M. Gundy, and N.K. Aaronson Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study Support Care Cancer 20 2012 107 117
20. E.S. Hsu A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics Am J Ther 17 2010 476 486
21. C. Ito, Y. Isobe, H. Kijima, Y. Kiuchi, H. Ohtsuki, and R. Kawamura The anti-emetic activity of GK-128 in Suncus murinus Eur J Pharmacol 285 1995 37 43
22. S. Kapur, and G. Remington Serotonin-dopamine interaction and its relevance to schizophrenia Am J Psychiatry 153 1996 466 476 (Pubitemid 26113309)
23. M.G. Kris, R.J. Gralla, L.B. Tyson, and R.A. Clark Antiemetics and cytotoxic drugs Br Med J (Clin Res Ed) 287 1983 363 364 (Pubitemid 13074915)
24. M. Kwiatkowska, L.A. Parker, P. Burton, and R. Mechoulam A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew) Psychopharmacology (Berl) 174 2004 254 259 (Pubitemid 38916299)
25. C.L. Limebeer, and L.A. Parker Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea Neuroreport 10 1999 3769 3772 (Pubitemid 30005439)
26. C.L. Limebeer, and L.A. Parker The antiemetic drug ondansetron interferes with lithium-induced conditioned rejection reactions, but not lithium-induced taste avoidance in rats J Exp Psychol Anim Behav Process 26 2000 371 384
27. C.L. Limebeer, and L.A. Parker The 5-HT1A agonist 8-OH-DPAT dose-dependently interferes with the establishment and the expression of lithium-induced conditioned rejection reactions in rats Psychopharmacology (Berl) 166 2003 120 126 (Pubitemid 36313118)
28. C.L. Limebeer, D.E. Litt, and L.A. Parker Effect of 5-HT3 antagonists and a 5-HT(1A) agonist on fluoxetine-induced conditioned gaping reactions in rats Psychopharmacology (Berl) 203 2009 763 770
29. L. Lohr Chemotherapy-induced nausea and vomiting Cancer J 14 2008 85 93
30. N. Matsuki, S. Ueno, T. Kaji, A. Ishihara, C.H. Wang, and H. Saito Emesis induced by cancer chemotherapeutic agents in the Suncus murinus: a new experimental model Jpn J Pharmacol 48 1988 303 306
31. W.D. Miner, G.J. Sanger, and D.H. Turner Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis Br J Cancer 56 1987 159 162 (Pubitemid 17155531)
32. C. Morran, D.C. Smith, D.A. Anderson, and C.S. McArdle Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics Br Med J 1 1979 1323 1324 (Pubitemid 9172412)
33. G.R. Morrow, J.T. Hickok, and S.N. Rosenthal Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban) Cancer 76 1995 343 357
34. G.R. Morrow, J.A. Roscoe, J.J. Kirshner, H.E. Hynes, and R.J. Rosenbluth Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics Support Care Cancer 6 1998 244 247 (Pubitemid 28213060)
35. A. Naeim, S.M. Dy, K.A. Lorenz, H. Sanati, A. Walling, and S.M. Asch Evidence-based recommendations for cancer nausea and vomiting J Clin Oncol 26 2008 3903 3910
36. H. Nakayama, H. Yamakuni, M. Higaki, H. Ishikawa, K. Imazumi, and M. Matsuo Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets J Pharmacol Sci 98 2005 396 403 (Pubitemid 41297013)
37. C.J. Niemegeers Antiemetic specificity of dopamine antagonists Psychopharmacology (Berl) 78 1982 210 213 (Pubitemid 13250844)
38. L.A. Parker, and C.L. Limebeer Conditioned gaping in rats: a selective measure of nausea Auton Neurosci 129 2006 36 41 (Pubitemid 44470862)
39. L.A. Parker, R. Mechoulam, and C. Schlievert Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats Neuroreport 13 2002 567 570 (Pubitemid 34293468)
40. L.A. Parker, R. Mechoulam, C. Schlievert, L. Abbott, M.L. Fudge, and P. Burton Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea Psychopharmacology (Berl) 166 2003 156 162 (Pubitemid 36313122)
41. L.A. Parker, M. Kwiatkowska, P. Burton, and R. Mechoulam Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew) Psychopharmacology (Berl) 171 2004 156 161 (Pubitemid 38134652)
42. L.A. Parker, S.A. Rana, and C.L. Limebeer Conditioned nausea in rats: assessment by conditioned disgust reactions, rather than conditioned taste avoidance Can J Exp Psychol 62 2008 198 209
43. D.A. Perwitasari, H. Gelderblom, J. Atthobari, M. Mustofa, I. Dwiprahasto, and J.W. Nortier Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics Int J Clin Pharmacol 33 2011 33 43
44. D.J. Potter, P. Clark, and M.B. Brown Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology J Forensic Sci 53 2008 90 94 (Pubitemid 351239216)
45. E.M. Rock, and L.A. Parker Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats Br J Pharmacol 169 2013 685 692
46. E.M. Rock, J.M. Goodwin, C.L. Limebeer, A. Breuer, R.G. Pertwee, and R. Mechoulam Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews Psychopharmacology (Berl) 215 2011 505 512
47. E. Rock, D. Bolognini, C. Limebeer, M. Cascio, S. Anavi-Goffer, and P. Fletcher Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus Br J Pharmacol 165 2012 2620 2634
48. J.A. Rudd, and R.J. Naylor Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret Neuropharmacology 33 1994 1607 1608
49. J.A. Rudd, M.P. Ngan, and M.K. Wai 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin Eur J Pharmacol 352 1998 143 149 (Pubitemid 28345111)
50. R. Saller, D. Hellenbrecht, L. Briemann, A. Hellstern, H. Hess, and P. Mitrou Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis Clin Pharmacol Ther 37 1985 43 47 (Pubitemid 16225165)
51. T.S. Sam, J.T. Cheng, K.D. Johnston, K.K. Kan, M.P. Ngan, and J.A. Rudd Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew) Eur J Pharmacol 472 2003 135 145 (Pubitemid 36830999)
52. T. Sharp, S.R. Bramwell, and D.G. Grahame-Smith 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis Br J Pharmacol 96 1989 283 290 (Pubitemid 19045101)
53. M. Tonato, F. Roila, A. del Favero, G. Tognoni, M.G. Franzosi, and S. Pampallona A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin Eur J Cancer Clin Oncol 21 1985 807 810 (Pubitemid 15028506)
54. Y. Torii, H. Saito, and N. Matsuki Selective blockade of cytotoxic drug-induced emesis by 5-HT3 receptor antagonists in Suncus murinus Jpn J Pharmacol 55 1991 107 113
55. K.J. Tuerke, C.L. Limebeer, P.J. Fletcher, and L.A. Parker Double dissociation between regulation of conditioned disgust and taste avoidance by serotonin availability at the 5-HT3 receptor in the posterior and anterior insular cortex J Neurosci 32 2012 13709 13717
56. K.J. Tuerke, B.D. Winters, and L.A. Parker Ondansetron interferes with unconditioned lying-on belly and acquisition of conditioned gaping induced by LiCl as models of nausea-induced behaviors in rats Physiol Behav 105 2012 856 860
57. R.L. Wynn, E. Essien, and P.D. Thut The effects of different antiemetic agents on morphine-induced emesis in ferrets Eur J Pharmacol 241 1993 47 54 (Pubitemid 23268335) Canada